SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001516551-22-000006
Filing Date
2022-05-06
Accepted
2022-05-06 17:07:50
Documents
63
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q skye-20220331.htm   iXBRL 10-Q 943470
2 EX-31.1 skye-20220331xex311.htm EX-31.1 10590
3 EX-31.2 skye-20220331xex312.htm EX-31.2 11119
4 EX-32.1 skye-20220331xex321.htm EX-32.1 5171
5 EX-32.2 skye-20220331xex322.htm EX-32.2 5311
  Complete submission text file 0001516551-22-000006.txt   5259177

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20220331.xsd EX-101.SCH 49380
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skye-20220331_cal.xml EX-101.CAL 49489
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skye-20220331_def.xml EX-101.DEF 212667
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20220331_lab.xml EX-101.LAB 551910
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20220331_pre.xml EX-101.PRE 337942
57 EXTRACTED XBRL INSTANCE DOCUMENT skye-20220331_htm.xml XML 764933
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 22902268
SIC: 2834 Pharmaceutical Preparations